Phibro Animal Health Corporation Überblick
Branche: Drug Manufacturers Specialty & Generic
Sektor: Healthcare
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy cattle, aquaculture, and dogs. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. The company also offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. In addition, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey. Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and market
Research-Überblick
Letztes Berichtsdatum 2026-08-26Diese Mavefund-Research-Seite bündelt geprüfte Informationen zu Phibro Animal Health Corporation (PAHC): Unternehmensprofil, Kursverlauf, verknüpfte Primärquellen, verfügbare Finanzberichte, Research-Signale und zu prüfende Risiken.
- Börsennotierung
- PAHC · Nasdaq · MIC XNAS
- Land
- United States
- Handelswährung
- USD
- Branche
- Drug Manufacturers Specialty & Generic
- Finanzdaten
- Jahres- und Zwischenabschlüsse verfügbar
- Letzte Primärquelle
- SEC EDGAR · veröffentlicht 2026-08-26
- Letzter Bericht · SEC EDGAR Veröffentlicht 2026-08-26
- Registrierungsdokument
Die Abdeckung wird automatisch aktualisiert und erst nach einer Datenintegritätsprüfung veröffentlicht. Nur Research-Unterstützung; keine persönliche Anlageberatung.
Mavefund ordnet die verfügbaren Fundamentaldaten, Bewertungskennzahlen und Risikofaktoren von Phibro Animal Health Corporation für einen nachvollziehbaren Research-Prozess ein.
Score
Veröffentlichte Ergebnisse
Was das Unternehmen berichtet hat – mit kompakter Quellenangabe.
Quarterly result summary
Net sales was $396.7M (+5% YoY); EPS was $0.53 (reported).
Was sich verändert hat
- Net sales +5% YoY to $396.7M; EPS reported to $0.53.
- Capital return update: free cash flow $9.9M.
Guidance / outlook
we expect continued growth across our businesses.
Source: SEC EDGAR company-filed earnings materials. Dates and source identifiers are retained for verification; review the original filing before relying on extracted report details.
Weitere aktuelle Ergebnisunterlagen
Geprüfte Signal-Evidenz
Aktuelle Nachrichten
Unternehmensrelevante Artikel aus Quellen, die die Relevanz- und Zuverlässigkeitsprüfung des Mave Signals bestehen.
PAHC Q2 Deep Dive: Diverse Portfolio Offsets Regulatory and Margin Headwinds
Headline from Yahoo Finance: PAHC Q2 Deep Dive: Diverse Portfolio Offsets Regulatory and Margin Headwinds.
Phibro Animal Health Q4 Earnings Call Highlights
Headline from Yahoo Finance: Phibro Animal Health Q4 Earnings Call Highlights.
Phibro Animal Health Corporation Q4 2026 Earnings Call Summary
Headline from Yahoo Finance: Phibro Animal Health Corporation Q4 2026 Earnings Call Summary.
Phibro (PAHC) Reports Q4 Earnings: What Key Metrics Have to Say
Headline from Yahoo Finance: Phibro (PAHC) Reports Q4 Earnings: What Key Metrics Have to Say.
Phibro Animal Health (PAHC) Tops Q4 Earnings and Revenue Estimates
Headline from Yahoo Finance: Phibro Animal Health (PAHC) Tops Q4 Earnings and Revenue Estimates.
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
Headline from Business Wire: Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance.
Gewinn je Aktie
Eigenkapitalrendite
Eigenkapitalrendite
Unternehmen —
Sektormedian —
Eigenkapitalrendite
Unternehmen —
Sektormedian —
Eigenkapitalrendite
Unternehmen —
Sektormedian —
Eigenkapitalrendite
Unternehmen —
Sektormedian —
Kennzahlen-Chart vorübergehend nicht verfügbar.
Nettomarge
Nettomarge
Unternehmen —
Sektormedian —
Nettomarge
Unternehmen —
Sektormedian —
Nettomarge
Unternehmen —
Sektormedian —
Nettomarge
Unternehmen —
Sektormedian —
Kennzahlen-Chart vorübergehend nicht verfügbar.
Verschuldung
Verschuldungsgrad
Unternehmen —
Sektormedian —
Verschuldungsgrad
Unternehmen —
Sektormedian —
Verschuldungsgrad
Unternehmen —
Sektormedian —
Verschuldungsgrad
Unternehmen —
Sektormedian —
Kennzahlen-Chart vorübergehend nicht verfügbar.
Finanzberichte
Vom Unternehmen veröffentlichte Berichtsdaten, strukturiert und mit der Originalquelle verknüpft.
Quellendetails werden mit den Berichtsdaten geladen. Die Werte sind standardisierte Unternehmensangaben zur Research-Unterstützung, keine persönliche Anlageberatung.